CClinicalTrials.gg
CompletedNCT06449924Updated May 14, 2026

An Endotracheal Tube Inserted to the Level of the Hypopharynx

An observational study in Intubation; Difficult or Failed, Pediatric ALL and Ventilator Lung, sponsored by American University of Beirut Medical Center. Completed at 1 site in Lebanon. Open to participants aged 1 Month to 6 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-14.

Sponsored by American University of Beirut Medical Center · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
85
Ages
1 Month to 6 Years
Sex
All
01

Study summary

The goal of this observational study is to assess the incidence of successful ventilation using an ETT inserted orally above the vocal cords in pediatric patients undergoing surgeries. The main question it aims to answer are:

Is the use of an endotracheal tube (ETT), positioned in the hypopharynx with its tip placed just above the vocal cords an easy, safe and effective way for the ventilation of pediatric patients who are undergoing surgery under general anesthesia via orotracheal intubation?

The procedures to be performed in this study are standard of care. They are also used by pediatric anesthesiologists in the oral intubation of pediatric patients suffering from tumor or abscess.

Read the detailed description

Background: Tracheal intubation can be challenging in the pediatric age group. The difficult airway algorithm is followed starting with ventilation via a facemask. In cases of difficulties in intubation and ventilation, and especially in neonates and small infants, oxygen desaturation can happen very quickly and can be life threatening. The endotracheal tube (ETT), which is readily available and bypasses the tongue of the patient, can provide a safe and efficient ventilation.

Specific Aim (s): In our study, we aim at assessing the incidence of successful ventilation using an ETT inserted orally above the vocal cords in pediatric patients undergoing surgeries. Secondary objectives include assessing the incidence of severe hypoxemia (SpO2 \< 85%) along with other adverse events, such as bradycardia, stomach insufflation, and laryngospasm

Methods: This prospective, observational study will include 85 infants and small children aged > 1 month and ≤ 6 years old, undergoing elective surgery under general anesthesia with orotracheal intubation. The effectiveness and safety of hypopharyngeal ETT ventilation performed by clinical anesthesia (CA) residents will be evaluated. The primary objective of this study is to assess the efficacy of this technique in providing successful ventilation evidenced by visible chest rise, the presence of a sustained end-tidal capnography (EtCO2) waveform, stable oxygen saturation (SpO2) values, and an adequate expired tidal volume. Secondary outcomes include the incidence of severe hypoxemia (SpO2 \< 85%), bradycardia, stomach insufflation, and laryngospasm.

Significance: This ETT technique is simple to implement and use, requiring no special training or equipment. This technique can save time by ensuring patients' oxygenation and ventilation.

02

Conditions studied

  • Intubation; Difficult or Failed
  • Pediatric ALL
  • Ventilator Lung
03

In context

Precursor Cell Lymphoblastic Leukemia-Lymphoma

2,061 studies on the registry are indexed under Precursor Cell Lymphoblastic Leukemia-Lymphoma; 490 are open to participants now.

This study's enrollment of 85 is below the median of 120 across 300 observational studies indexed under Precursor Cell Lymphoblastic Leukemia-Lymphoma.

Browse Precursor Cell Lymphoblastic Leukemia-Lymphoma studies →

Lead sponsor

American University of Beirut Medical Center is the lead sponsor of 152 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 6 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Infants and children who are > 1 month and ≤ 6 years old undergoing elective surgeries at the American University of Beirut Medical Center (AUBMC).

Inclusion criteria

  • Age > 1 month and ≤ 6 years
  • Legal guardian/representative willing to sign consent

Exclusion criteria

Exclusion Criteria:

  • BMI > 30 kg/m2
  • Patient with a risk of aspiration of history of GERD
  • Inability or unwillingness of research participant's legal guardian/ representative to give consent
  • Need for emergency surgery
  • ASA Ⅲ-Ⅳ
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
85 participants (actual)
Patient registry
No

Interventions

  • DeviceEndotracheal tube

    Endotracheal Tube Inserted to the Level of the Hypopharynx

06

What researchers measure

Primary outcomes

  1. Successful ventilation

    Successful ventilation which is evaluated according to the following criteria: Delivery of adequate expired tidal volume, a stable value of SpO2, and at least eight end tidal CO2 waveforms.

    Time frame: During intubation

Secondary outcomes

  1. Incidence of severe hypoxemia

    Incidence of severe hypoxemia (SPO2 less than 85%)

    Time frame: During intubation

  2. Incidence of adverse events

    Incidence of adverse events such as bradycardia, stomach insufflation, and laryngospasm

    Time frame: During intubation

07

Study locations

1 site
  • American University of Beirut Medical Center
    Beirut, Lebanon
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06449924
Lead sponsor
American University of Beirut Medical Center
Responsible party
Roland Kaddoum (Principal Investigator, American University of Beirut Medical Center) — Principal investigator
First posted
Jun 10, 2024
Start date
Jun 21, 2024
Primary completion
Aug 22, 2025
Completion
Aug 22, 2025
Last update
May 14, 2026

Study contacts

Roland Kaddoum, MD
principal investigator · American University of Beirut Medical Center

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion